🇨🇦·4d agoIndustry
Zymeworks Announces Presentations for Ziihera® (zanidatamab-hrii) at 2026 AACR Annual Meeting
Publisher
Z
Zymeworks
Canada
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalIn-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on ir.zymeworks.com
Leave the platform to read the original full article on the publisher site.
Source: Zymeworks
Scope: Industry
Related coverage
More related coverage
IDEAYA Biosciences·1d ago
IDEAYA Biosciences Upcoming Investor Relations Events and Updated Darovasertib Topline Results Guidance from Phase 2/3 OptimUM-02 Trial
IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the disc...
Mirati Therapeutics (BMS)·3d ago
Subscribe to Press release email alerts
Sign up for BMY email alerts and receive timely updates on press releases.
argenx US·3d ago
argenx announces Annual General Meeting of Shareholders on May 6, 2026
argenx US·3d ago